Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

804
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
804
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

213
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
213
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

219
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

589
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
589

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sodium-Glucose Cotransporter 2 Inhibitors as Discharge Medications in Survivors of Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Shock (Augusta, Ga.)·2026
Same author

Middle East Bifurcation Club Consensus Document on Percutaneous Revascularization of Bifurcation Lesions in Association with the National Heart Center <i>- Saudi Health Council</i>.

Saudi medical journal·2026
Same author

Postangiography Prediction of Renal Replacement Therapy in Acute Myocardial Infarction-Related Cardiogenic Shock: Least Absolute Shrinkage and Selection Operator Nomogram Development and Validation.

JMIR cardio·2026
Same author

Effect of mechanical circulatory support on outcomes in patients with cardiogenic shock secondary to acute myocardial infarction.

Scientific reports·2026
Same author

Phenotyping cardiogenic shock: an insight from the gulf cardiogenic shock registry.

Frontiers in artificial intelligence·2026
Same author

Residual Cardiovascular Risk Associated with Non-HDL-C in Statin-Treated Patients: Data from the Gulf Triglyceride and Residual Cardiovascular Risk (Gulf CALLS) Cohort.

Angiology·2026

Related Experiment Video

Updated: Jan 15, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.7K

Improving ST-Elevation Myocardial Infarction (STEMI) Care Through the Bahrain Stent Save a Life (BaSSaL) Program: A

Haitham Amin1, Husam Noor2, Fuad Abdulqader1

  • 1Interventional Cardiology, Mohammed Bin Khalifa Bin Salman Al Khalifa Specialist Cardiac Centre, Awali, BHR.

Cureus
|October 13, 2025
PubMed
Summary

This study analyzed ST-elevation myocardial infarction (STEMI) patients in Bahrain, finding that improving access to primary percutaneous coronary intervention (PPCI) is crucial for reducing mortality and ischemic time.

Keywords:
bahrainmyocardial infarctionprimary pciregistry datast-elevation myocardial infarction (stemi)

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.6K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.3K

Related Experiment Videos

Last Updated: Jan 15, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.7K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.6K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.3K

Area of Science:

  • Cardiology
  • Public Health

Background:

  • ST-elevation myocardial infarction (STEMI) remains a leading cause of cardiovascular mortality worldwide.
  • Timely reperfusion therapy, such as primary percutaneous coronary intervention (PPCI), is critical for improving outcomes in STEMI patients.

Purpose of the Study:

  • To characterize the clinical features of STEMI patients in Bahrain.
  • To identify predictors of adverse cardiovascular events in this population.
  • To evaluate the effectiveness of PPCI in reducing mortality and ischemic time.

Main Methods:

  • A prospective, single-center study included 787 patients presenting with STEMI between January 2022 and December 2022.
  • All patients underwent primary percutaneous coronary intervention (PPCI).
  • Patient outcomes were monitored for one year post-hospitalization.

Main Results:

  • The study population comprised 787 patients, with a majority being male (91.5%) and a mean age of 56.6 years.
  • Non-Bahraini patients constituted 62% of the cohort.
  • In-hospital mortality was 4.2%, with a one-year mortality of 6.7%. Stent thrombosis occurred in 1.0% of patients.

Conclusions:

  • Nationwide registries like the Bahrain Stent Save a Life (BaSSaL) project are vital for identifying implementation barriers for STEMI guidelines.
  • Improving patient access to PPCI is essential for reducing total ischemic time and mortality.
  • Adherence to target revascularization timelines can significantly improve STEMI patient survival.